Degradation and inactivation of rat atrial natriuretic peptide 1-28 by neutral endopeptidase-24.11 in rat pulmonary membranes.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Regulatory Peptides

• Publication date

  1992-11-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0167-0115(92)90026-QPMID 1475409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radio-immunoassay of atrial natriuretic peptide (ANP) and characterization of ANP immunoreactivity in human plasma and atrial tissue.

  1992cited by this paper
• Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral Endopeptidase

  1991cited by this paper
• Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

  1991cited by this paper
• Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.

  1991cited by this paper
• Degradation and clearance of atrial natriuretic factors (ANF).

  1990cited by this paper
• Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications.

  1990cited by this paper
• Synthesis and biological activity of atrial natriuretic factor analogues: effect of modifications to the disulfide bridge.

  1990cited by this paper
• Mechanisms of atrial natriuretic factor-induced vasodilation.

  1990cited by this paper
• Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humans.

  1990cited by this paper
• Atrial Natriuretic Factor‐Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor

  1990cited by this paper
• Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.

  1989cited by this paper
• Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.

  1989cited by this paper
• Atrial natriuretic peptide: its mechanism of release from the atrium.

  1989cited by this paper
• Structure, expression, and function of atrial natriuretic factor in extraatrial tissues.

  1989cited by this paper
• Degradation of atrial natriuretic peptide in dogs.

  1989cited by this paper
• Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1

  1989cited by this paper
• Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

  1989cited by this paper
• Degradation of atrial natriuretic peptides by an enzyme in rat kidney resembling neutral endopeptidase 24.11.

  1988cited by this paper
• Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive rats.

  1988cited by this paper
• Vasodilator responses to alpha-human-atrial natriuretic peptide in isolated omental and pulmonary arteries from rabbit and man.

  1988cited by this paper
• Contribution of the kidney to metabolic clearance of atrial natriuretic peptide.

  1988cited by this paper
• Chemical synthesis and structure-activity relations for ANF analogues.

  1987cited by this paper
• Atrial Natriuretic Factor in Acute and Chronic Cardiac Failure

  1987cited by this paper
• The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

  1987cited by this paper
• Organ extraction of atrial natriuretic peptide (ANP) in man. Significance of sampling site.

  1987cited by this paper
• Disappearance of atrial natriuretic factor from circulation in the rat.

  1986cited by this paper
• Atrial Natriuretic Peptide in Humans: Production and Clearance by Various Tissues

  1986cited by this paper
• Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.

  1986cited by this paper
• Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide.

  1985cited by this paper
• Neutral metalloendopeptidase in human lung tissue and cultured cells.

  1985cited by this paper
• Depressor and natriuretic activities of several atrial peptides.

  1984cited by this paper
• Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels.

  1983cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• Enkephalinase activity in rat peripheral organs.

  1981cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• presence of moderate left atrial hypertension in sheep Alveolar epithelial fluid clearance persists in the

  2015cites this paper
• Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates.

  2003cites this paper
• Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep.

  1999cites this paper
• Evidence for functional ANP receptors in cultured alveolar type II cells.

  1998cites this paper
• Evidence for functional ANP receptors in cultured alveolar type II cells.

  1998cites this paper
• Conversion of Big Endothelin-1 and Characterization of Its Contractile Effects on Isolated Human Placental Arteries

  1998cites this paper
• Molecular Determinants of Natriuretic Peptide Clearance Receptor Function

  1997cites this paper
• Role of atrial natriuretic factor in lung physiology and pathology.

  1995cites this paper
• Neutral endopeptidase in the heart. Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation.

  1994cites this paper
• Degradation and inactivation of human atrial natriuretic peptide by human pulmonary plasma membranes.

  1993cites this paper